Nordic Register and Biobank Data

Size: px
Start display at page:

Download "Nordic Register and Biobank Data"

Transcription

1 Nordic Register and Biobank Data A basis for innovative research on health and welfare Juni Palmgren Karolinska Institutet, Stockholm Nordic conference on Real World Data Helsinki November 2016

2 Nordic populations 5,5M 0,3M 9,3M 5,3M 4,9M J Palmgren 2

3 Nordic population based registries LIFE SPAN REGISTRIES EARLY LIFE Cancer Hospital Discharge LATE LIFE Birth Congenital Malformations Clinical Quality Registries Specific Disease Registries Register of prescribed drug sales Cause of Death L I F E GENETICALLY INFORMATIVE Population Multiple Generation Twin Migration 3

4 The biobank perspective Genomes (Sanger, EBI + NCBI) Nucleotide sequence EMBL-Bank+Genbank+DDBj Gene expression ArrayExpress, GEO Protein families, motifs and domains InterPro (12 collaborators) Protein interactions IntAct with Imex, PRIDE Pathways Kegg; Reactome Protein sequence UniProt(EBI/SIB/PIR) Protein structure wwpdb(rcsb,ebi,pdbj) Chemical entities ChEBI; PubChem From molecules to systems Systems BioModels From Janet Thornton, EBI

5 A longitudinal perspective on health and disease Personalized diagnostics and treatment Cured Healthy Diagnosis Chronic/current disease Dead time 12 december

6 Type 2 Diabetes > individuals National Biobanks Finland portal individuals from population cohorts individuals from disease collections Cardiovascular events stroke, CHD individuals Life course events High Blood pressure Cardiovascular risk factor data individuals REGISTROMICS Severe mental health: Social security number Cause of death data - schizophrenia, depression - > 5000 individuals Prescription medication data Migraine individuals National Biobank individuals statin users estrogen substitution th Old age dementia, ~ 5000 individuals Cancer > cases Life style and socio-economic data - education, economic state, smoking

7 Data integration and interoperability? Fantastic opportunities! Obstacles: Many data owners Multitude of regulations and practices Weak documentation, metadata, ontologies Secure sharing? Norden? Tedious and complicated within countries more so between countries J Palmgren 7

8 Nordic research data Nordic Council of Ministers (NCM) Marie Sandberg, CSC, 2012 Challenges from six perspectives: The political perspective The organizational perspective The legal perspective The financial perspective The ethical perspective The technical perspective The lack of a Nordic perspective for research data implies a risk of developing policy directives which are not aligned on the Nordic level.

9 A vision A Nordic Commons A shared virtual space where scientists can work with the digital objects of biomedical research. This is a system that will allow investigators to find, manage, share, use and reuse data, software, metadata and workflows. From Data Science at NIH

10 Components of a Commons ecosystem from A computing environment, such as the cloud and/or HPC (High Performance Computing) resources, which support access, utilization and storage of digital objects. Data sets that adhere to a set of Digital Object Compliance Principles which describe the properties of digital objects that enables them to be findable, accessible, interoperable and reproducible (FAIR). Software services and tools that enable; Scalable provisioning of compute resources. Interoperability between digital objects within the Commons. Indexing and thus discoverability of digital objects. Sharing of digital objects between individuals or groups. Access to and deployment of scientific analysis tools and pipeline workflows. Connectivity with other repositories, registries and resources that support scholarly research.

11 A Nordic context (Common pot initiative) The NordForsk Programme on Health and Welfare Academy of Finland, Danish Research Council for Independent Research/Medical Sciences, Icelandic Centre of Research (Rannis), The Research Council of Norway, The Swedish Research Council for Health, Working Life and Welfare (FORTE) The Swedish Research Council NordForsk. The Programme runs from 2014 to 2018, covers 11 research projects in The perspective is broad. From 2017 a Research Infrastructure and an education component are planned as part of the Programme

12 A Nordic Commons would rely on A clear legal and ethical framework for sharing data and tools across borders Transparency and an open access policy Involvement of a broad range of Nordic key stakeholders Political level (legislation and ethics) Research funding level National data-owner institutions escience and einfrastructure expertize Scientists The Nordic countries need to tap into the ongoing discussions on Open Science and data sharing in the contect of the EU Open Science Cloud and other international initiatives.

13 Open access to scientific information

14 J Palmgren 14

15

16 Summary Recommendations for Norden Legislation: Coordinate national legislation and legal practices in the wake of new EU GDPR. Harmonize handling of sensitive research data from registers, cohorts, biobanks and molecular data repositories Ethics: Set up a simplified and coherent ethics review process for cross-nordic studies Metadata: Create compatible meta-data models within and across Nordic data sources. Open Access: Coordinate high level demands for open access to data and methods. A Nordic Commons: Work towards an integrated system for finding, managing, sharing, using and reusing data, software, metadata and workflows

17 Sharing Mine! across organisations disciplines geographical and institutional boarders research groups and scientists Beware of financial, organisational, technical, legal, ethical, cultural obstacles 17

Nordic health data project. Magnus Eriksson, Chair of metadatagroup 28. nov 2018

Nordic health data project. Magnus Eriksson, Chair of metadatagroup 28. nov 2018 Nordic health data project Magnus Eriksson, Chair of metadatagroup 28. nov 2018 Research Infrastructure for Nordic Health Data NordForsk Program on Health and Welfare Recent background: NordForsk Policy

More information

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine Nordic Common Strengths and Future Potential in the Field of Personalised Medicine NOS-M Workshop 23rd November 2016 Stockholm Waterfront Johan Nilsson Coordinator Medicine and Health Swedish Research

More information

European Genome phenome Archive at the European Bioinformatics Institute. Helen Parkinson Head of Molecular Archives

European Genome phenome Archive at the European Bioinformatics Institute. Helen Parkinson Head of Molecular Archives European Genome phenome Archive at the European Bioinformatics Institute Helen Parkinson Head of Molecular Archives What is EMBL-EBI? International, non-profit research institute Part of the European Molecular

More information

Elixir: European Bioinformatics Research Infrastructure. Rolf Apweiler

Elixir: European Bioinformatics Research Infrastructure. Rolf Apweiler Elixir: European Bioinformatics Research Infrastructure Rolf Apweiler EMBL-EBI Service Mission To enable life science research and its translation to medicine, agriculture, the bioindustries and society

More information

Introduction to EMBL-EBI.

Introduction to EMBL-EBI. Introduction to EMBL-EBI www.ebi.ac.uk What is EMBL-EBI? Part of EMBL Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, the Netherlands,

More information

Professor Ewan Birney FRS Director, EMBL-EBI

Professor Ewan Birney FRS Director, EMBL-EBI Infrastructures for research and innovation Professor Ewan Birney FRS Director, EMBL-EBI www.ebi.ac.uk Outline of talk Who Am I, What is EMBL? The change in genomics The needs for stratified patients in

More information

Global Biomolecular Information Infrastructure and Australia. Graham Cameron Director The EMBL Australia Bioinformatics Resource

Global Biomolecular Information Infrastructure and Australia. Graham Cameron Director The EMBL Australia Bioinformatics Resource Global Biomolecular Information Infrastructure and Australia Graham Cameron Director The EMBL Australia Bioinformatics Resource What is bioinformatics? Methods, data, IT to exploit biomolecular information

More information

Elixir: Overview, Progress and Futures

Elixir: Overview, Progress and Futures Elixir: Overview, Progress and Futures 20th Meeting of the EC-US Biotechnology Task Force Barcelona 3 June 2010 Andrew Lyall, ELIXIR Project Manager www.elixir-europe.org ELIXIR: a sustainable infrastructure

More information

Finnish Biobanks. The most advanced testbed in the world

Finnish Biobanks. The most advanced testbed in the world Finnish Biobanks The most advanced testbed in the world Jaana Hartikainen, Ph.D., Adjunct Professor in Molecular Genetics Assistant Professor in Translational Cancer Research and Biobank Research University

More information

Interpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI

Interpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI Interpreting Genome Data for Personalised Medicine Professor Dame Janet Thornton EMBL-EBI Deciphering a genome 3 billion bases 4 million variants 21,000 coding variants 10,000 non-synonymous variants 50-100

More information

~1O % of the population = 500,000 Finns

~1O % of the population = 500,000 Finns 1 2 ~1O % of the population = 500,000 Finns Goals of FinnGen 3 01 03 PRODUCE MEDICAL INNOVATIONS BY COMBINING HEALTH REGISTRY AND GENOME DATA CREATE A CO-OPERATION MODEL BETWEEN PUBLIC SECTOR AND HEALTHCARE

More information

BBMRI.NL A story of Sharing Eline Slagboom Molecular Epidemiology, Leiden University Medical Center Brussel 20 Juni 2017

BBMRI.NL A story of Sharing Eline Slagboom Molecular Epidemiology, Leiden University Medical Center Brussel 20 Juni 2017 BBMRI.NL A story of Sharing Eline Slagboom Molecular Epidemiology, Leiden University Medical Center Brussel 20 Juni 2017 BBMRI-NL TOWARDS A NATIONAL BIOBANKING INFRASTRUCTURE Founded in 2009 as the Dutch

More information

Towards standard, accessible and reproducible Metabolomics

Towards standard, accessible and reproducible Metabolomics Towards standard, accessible and reproducible Metabolomics Reza Salek PhD Metabolism and Molecular Informatics The European Bioinformatics Institute (EMBL-EBI) Email: Reza.salek@ebi.ac.uk The 1st International

More information

Future of the Project. BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton

Future of the Project. BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton Future of the Project BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton What were goals of BioMedBridges? GOAL 1: To provide computational data and service bridges between

More information

dixa-a data infrastructure for chemical safety Jos Kleinjans Dept of Toxicogenomics Maastricht University

dixa-a data infrastructure for chemical safety Jos Kleinjans Dept of Toxicogenomics Maastricht University dixa-a data infrastructure for chemical safety Jos Kleinjans Dept of Toxicogenomics Maastricht University Big data in toxicogenomics The amountof data in ourworldhas been exploding. And the abilityto store,

More information

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.

More information

Aarno Palotie, M.D., Ph.D.

Aarno Palotie, M.D., Ph.D. Aarno Palotie, M.D., Ph.D. 1 Genetics and big data The technology drives the change Need of large samples EACH GENE VARIANT HAS A SMALL EFFECT The challenge: we can write down genomes, but we don t yet

More information

Health Analytics Current data situation and use in Norway

Health Analytics Current data situation and use in Norway Health Analytics Current data situation and use in Norway Anne Torill Nordsletta, Director Health Analytics, Norwegian Centre for E-health Research @ ehealthnorway 2016 Established NORWEGIAN CENTRE FOR

More information

Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017

Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017 New Tools for Personalized Medicine *Tools = Assays, Devices, Software Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017 http://epigenomics.cemm.oeaw.ac.at http://biomedical-sequencing.at

More information

ELIXIR: data for molecular biology and points of entry for marine scientists

ELIXIR: data for molecular biology and points of entry for marine scientists ELIXIR: data for molecular biology and points of entry for marine scientists Guy Cochrane, EMBL-EBI EuroMarine 2018 General Assembly meeting 17-18 January 2018 www.elixir-europe.org Scales of molecular

More information

all official ACS meetings and events without the express written consent from the ACS.

all official ACS meetings and events without the express written consent from the ACS. 248th American Chemical Society National Meeting & Exposition www.acs.org/sanfran2014 The use of any device to capture images (e.g., cameras and camera phones) or sound (e.g., tape and digital recorders)

More information

1.0 Background to the organisation

1.0 Background to the organisation 1.0 Background to the organisation The National University of Ireland Galway, the Royal College of Surgeons in Ireland, University College Cork, University College Dublin and Trinity College and their

More information

SAMPLE TITLE HERE. The Seven Bridges Cloud Ecosystem: Enabling Interoperable Data Access and Analysis. Liz Williams, PhD

SAMPLE TITLE HERE. The Seven Bridges Cloud Ecosystem: Enabling Interoperable Data Access and Analysis. Liz Williams, PhD The Seven Bridges Cloud Ecosystem: Enabling Interoperable Data Access and Analysis SAMPLE TITLE HERE 2018 Seven Bridges Liz Williams, PhD liz.williams@sbgenomics.com sevenbridges.com The content of this

More information

Bioinformatics: Present & Future from an EBI Perspective. Janet Thornton. UCL February 14 th 2012

Bioinformatics: Present & Future from an EBI Perspective. Janet Thornton. UCL February 14 th 2012 Bioinformatics: Present & Future from an EBI Perspective Janet Thornton UCL February 14 th 2012 What is bioinformatics? The science of storing, retrieving and analysing large amounts of biological information

More information

Genomics and personalised medicine

Genomics and personalised medicine Genomics and personalised medicine Dr Tom Fowler, Deputy Chief Scientist & Director of Public Health WHO Symposium on the Future of Digital Health Systems in the European Region February 2019 About me

More information

Workshop 4: Data Revolution (Room Louis Armand)

Workshop 4: Data Revolution (Room Louis Armand) Workshop 4: Data Revolution (Room Louis Armand) Moderator: Remi Salomon PhD, Vice-Chairman, AP-HP (FR) @APHP Roland Eils Data Management and Genomics Computing, Cancer Research Institute DKFZ (G) @CaptainSysBio

More information

Longitudinal Population Studies Strategy

Longitudinal Population Studies Strategy Longitudinal Population Studies Strategy Wellcome s Longitudinal Population Studies Working Group July 2017 Executive summary Opportunity Longitudinal population studies (LPS), which include cohorts, panel

More information

NIEHS and Data Integration

NIEHS and Data Integration NIEHS and Data Integration Where We ve Been and Where We re Going Linda Birnbaum, Ph.D., D.A.B.T., A.T.S. Director National Institute of Environmental Health Sciences National Toxicology Program Informing

More information

Arto Mannermaa. Research Manager, KUH Professor of personalized medicine and Biobanking, UEF

Arto Mannermaa. Research Manager, KUH Professor of personalized medicine and Biobanking, UEF Doctoral Programme of Clinical Research Introduction to Clinical Research, 2017 Arto Mannermaa Research Manager, KUH Professor of personalized medicine and Biobanking, UEF 040-3552752 arto.mannermaa@uef.fi

More information

INDIVIDUALIZED TREATMENT

INDIVIDUALIZED TREATMENT 1 INDIVIDUALIZED TREATMENT The healthcare system is under pressure: better budgetary compliance, quicker treatment, more equitable patient rights, and higher expectations from patients and relatives. These

More information

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER

More information

-YOUR PARTNER IN RESEARCH AND DEVELOPMENT

-YOUR PARTNER IN RESEARCH AND DEVELOPMENT -YOUR PARTNER IN RESEARCH AND DEVELOPMENT WHY CHOOSE NORWAY? A healthcare system with great opportunities for research....... 2 Unique and accessible health registries and biobanks........... 3 A great

More information

Open PHACTS: Semantic interoperability for drug discovery

Open PHACTS: Semantic interoperability for drug discovery Open PHACTS: Semantic interoperability for drug discovery ACS National Meeting, San Diego Herman van Vlijmen 16 Mar 2016 Judith Hinton Andrew, Rock Composite 22 Artwork from The Creative Center What is

More information

So we have a Digital repository in CSIRO now what? John Morrissey and Liam O Brien

So we have a Digital repository in CSIRO now what? John Morrissey and Liam O Brien So we have a Digital repository in CSIRO now what? John Morrissey and Liam O Brien Today s Agenda The DAP today Challenging times for building new eresearch capability Top down planning activities working

More information

The European Health Data & Evidence Network

The European Health Data & Evidence Network The European Health Data & Evidence Network What is it? Nigel Hughes EFPIA Coordinator Scientific Director, JCI Patient Data for Research, Janssen 18 th May 2018 1 All too often real world research is

More information

Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987

Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987 Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Human Genome Cells Nucleus Chromosome DNA Human Genome: 3 Billion Bases (letters) The Origin of

More information

mars Vision Paper !! December 2013 building the Microbial Antarctic Resource System MARS VISION PAPER

mars Vision Paper !! December 2013 building the Microbial Antarctic Resource System MARS VISION PAPER mars Vision Paper building the Microbial Antarctic Resource System December 2013 1 mars creating the Microbial Antarctic Resource System Vision Paper Alison Murray 1, Anton Van de Putte 2, Nabil Youdjou

More information

Overview of the Luxembourg biomedical and health research ecosystem FNR FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017

Overview of the Luxembourg biomedical and health research ecosystem FNR FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017 FNR Overview of the Luxembourg biomedical and health research ecosystem FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017 Research in Luxembourg Luxembourg : a young research location Creating structures

More information

Leonardo Mariño-Ramírez, PhD NCBI / NLM / NIH. BIOL 7210 A Computational Genomics 2/18/2015

Leonardo Mariño-Ramírez, PhD NCBI / NLM / NIH. BIOL 7210 A Computational Genomics 2/18/2015 Leonardo Mariño-Ramírez, PhD NCBI / NLM / NIH BIOL 7210 A Computational Genomics 2/18/2015 The $1,000 genome is here! http://www.illumina.com/systems/hiseq-x-sequencing-system.ilmn Bioinformatics bottleneck

More information

Nordic Trial Alliance Nordic Cooperation in Clinical Research

Nordic Trial Alliance Nordic Cooperation in Clinical Research Nordic Trial Alliance Nordic Cooperation in Clinical Research Mia Bengtström Nordic Trial Alliance Background Aim to strengthen clinical research in the Nordics Objective to contribute to sustainable Nordic

More information

Powering Translational Medicine with Semantic Web technologies

Powering Translational Medicine with Semantic Web technologies Powering Translational Medicine with Semantic Web technologies Michel Dumontier, Ph.D. Associate Professor of Medicine (Biomedical Informatics) Stanford University 1 Outline reproducible science linked

More information

ACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes

ACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes ACCELERATING GENOMIC ANALYSIS ON THE CLOUD Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia

More information

7800/16 AFG/evt 1 DG G 3 C

7800/16 AFG/evt 1 DG G 3 C Council of the European Union Brussels, 13 April 2016 (OR. en) 7800/16 RECH 92 TELECOM 43 NOTE From: To: Subject: Presidency Delegations Draft Council conclusions on the transition towards an Open Science

More information

Access to re-usable public sector information: the European Data Portal and the CEF programme

Access to re-usable public sector information: the European Data Portal and the CEF programme Access to re-usable public sector information: the European Data Portal and the CEF programme Daniele Rizzi, European Commission - DG Connect, Unit Data Value Chain Open (public) data: Why does it matter

More information

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution

More information

Introduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen

Introduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen Introduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen European Life Sciences Infrastructure for Biological Information www.elixir europe.org ELIXIR connects national bioinformatics centres

More information

Personalized. Health in Canada

Personalized. Health in Canada Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute

More information

Biotechnology Activities at the National Institutes of Health: Priorities and Trends. US-EU Task Force on Biotechnology Brussels, July, 2006

Biotechnology Activities at the National Institutes of Health: Priorities and Trends. US-EU Task Force on Biotechnology Brussels, July, 2006 Biotechnology Activities at the s of Health: Priorities and Trends US-EU Task Force on Biotechnology Brussels, July, 2006 s of Health Office of of the the Director on on Aging on on Alcohol Abuse and and

More information

Governing Interinstitutional

Governing Interinstitutional Governing Interinstitutional Research John F. Steiner, MD, MPH Senior Director Institute for Health Research Kaiser Permanente Colorado Chairman, Kaiser Permanente National Research Council Governing Board

More information

ELIXIR KPI framework and alignment of KPIs between e-infrastructures and research infrastructures

ELIXIR KPI framework and alignment of KPIs between e-infrastructures and research infrastructures ELIXIR KPI framework and alignment of KPIs between e-infrastructures and research infrastructures Rafael C Jimenez, ELIXIR CTO June 8, 2017 e-irg workshop June 2017 www.elixir-europe.org ELIXIR European

More information

EU Big Data Initiatives

EU Big Data Initiatives European Network of Excellence for Big Data in Hematology, consisting of 51 partners from 11 countries. Aliki Taylor, HARMONY Alliance Partner Director Global Health Outcomes, Takeda EU Big Data Initiatives

More information

Population Genetics & Drug Discovery

Population Genetics & Drug Discovery Population Genetics & Drug Discovery examples from Finland Mark J. Daly Chief, Analytic and Translational Genetics Unit Massachusetts General Hospital Co-director, Medical and Population Genetics Broad

More information

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary

More information

Virtual Physiological Human: From Global Vision to Clinical Practice

Virtual Physiological Human: From Global Vision to Clinical Practice Virtual Physiological Human: From Global Vision to Clinical Practice Karl A. Stroetmann & Marco Viceconti empirica, Bonn, Germany & Istituto Ortopedico Rizzoli, Bologna Italy with Rainer Thiel, empirica

More information

Maximising the value of research data: Wellcome Trust perspective

Maximising the value of research data: Wellcome Trust perspective Maximising the value of research data: Wellcome Trust perspective University of Cambridge 22 January 2016 David Carr Wellcome Trust d.carr@wellcome.ac.uk Slides made available under http://creativecommons.org/licenses/by/4.0/

More information

Introduc)on to Databases and Resources Biological Databases and Resources

Introduc)on to Databases and Resources Biological Databases and Resources Introduc)on to Bioinforma)cs Online Course : IBT Introduc)on to Databases and Resources Biological Databases and Resources Learning Objec)ves Introduc)on to Databases and Resources - Understand how bioinforma)cs

More information

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University Vision, aims and strategies Department of Immunology, Genetics and Pathology Uppsala University April19,2011 SCOPEOFACTIVITIESATIGP Research at the Department focuses on translational medicine through

More information

Network-centric Biomedicine: re-engineering the Knowledge Enterprise

Network-centric Biomedicine: re-engineering the Knowledge Enterprise Network-centric Biomedicine: re-engineering the Knowledge Enterprise Ken Buetow, Ph.D. Director Computational Science and Informatics Core Program, Complex Adaptive Systems Initiative Arizona State University

More information

THE CONVERGENCE INITIATIVE TO MAXIMISE THE VALUE FROM EUROPEAN RESEARCH

THE CONVERGENCE INITIATIVE TO MAXIMISE THE VALUE FROM EUROPEAN RESEARCH THE CONVERGENCE INITIATIVE TO MAXIMISE THE VALUE FROM EUROPEAN RESEARCH Georges De Moor EuroRec, Ghent University Electronic Health Records for Clinical Research 192 Growing number of Participating Projects

More information

Biomarkers as an emerging growth area in Denmark

Biomarkers as an emerging growth area in Denmark Biomarkers as an emerging growth area in Denmark International Conference on Perspectives in Precision Medicine, Copenhagen March 1, 2018 Kim Holmstrøm, PhD. Chairman of The Danish Biomarker Network R&D

More information

LIAISON ALLOY HEALTH PLATFORM

LIAISON ALLOY HEALTH PLATFORM PRODUCT OVERVIEW LIAISON ALLOY HEALTH PLATFORM WELCOME TO YOUR DATA-INSPIRED FUTURE THE LIAISON ALLOY HEALTH PLATFORM Healthcare and life sciences organizations are struggling to deal with unprecedented

More information

CAN GDPR WORK FOR HEALTH SCIENTIFIC RESEARCH? BRUSSELS OCTOBER 22 ND CIPL EFPIA FPF EXECUTIVE SUMMARY

CAN GDPR WORK FOR HEALTH SCIENTIFIC RESEARCH? BRUSSELS OCTOBER 22 ND CIPL EFPIA FPF EXECUTIVE SUMMARY CAN GDPR WORK FOR HEALTH SCIENTIFIC RESEARCH? BRUSSELS OCTOBER 22 ND 2018 - CIPL EFPIA FPF EXECUTIVE SUMMARY Despite many actors good intentions, the health research sector has so far survived GDPR rather

More information

New WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research

New WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research New WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research Hanne Bak Pedersen Programme Manager Health Technologies and Pharmaceuticals

More information

Gene therapy. Findings by Alert

Gene therapy. Findings by Alert Gene therapy Published Mar 21, 2000 Version 1 Findings by Alert Research in gene therapy has increased dramatically during the past 15 years, particularly in the United States. The research has encompassed

More information

Access to Information from Molecular Biology and Genome Research

Access to Information from Molecular Biology and Genome Research Future Needs for Research Infrastructures in Biomedical Sciences Access to Information from Molecular Biology and Genome Research DG Research: Brussels March 2005 User Community for this information is

More information

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, 2018 Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Overview Inova s Precision Medicine Journey MediMap

More information

All of Us Research Program

All of Us Research Program All of Us Research Program National Minority Quality Forum Stephanie Devaney, PhD Deputy Director, All of Us Research Program June 21, 2018 #joinallofus All of Us Mission and Objectives Nurture relationships

More information

Overview of Health Informatics. ITI BMI-Dept

Overview of Health Informatics. ITI BMI-Dept Overview of Health Informatics ITI BMI-Dept Fellowship Week 5 Overview of Health Informatics ITI, BMI-Dept Day 10 7/5/2010 2 Agenda 1-Bioinformatics Definitions 2-System Biology 3-Bioinformatics vs Computational

More information

Q4. WORK STREAMS Discovery, Cloud, Large Scale Genomics. DRIVER PROJECTS ELIXIR Beacon, EVA/EGA/ENA. WORK STREAMS Discovery

Q4. WORK STREAMS Discovery, Cloud, Large Scale Genomics. DRIVER PROJECTS ELIXIR Beacon, EVA/EGA/ENA. WORK STREAMS Discovery 2018 - Q4 Search The GA4GH Search API enables a search engine for genomic and clinical data by providing specification for query language across genomic, phenotypic, and clinical data that can be used

More information

GMI: Global Microbial Identifier

GMI: Global Microbial Identifier GMI: Global Microbial Identifier The future of microbiology: Identification and Surveillance will merge through the use of Whole Genome Sequencing (WGS) Jørgen Schlundt Professor Technical University of

More information

Welcome to the Ministry of Foreign Affairs

Welcome to the Ministry of Foreign Affairs Welcome to the Ministry of Foreign Affairs indk@um.dk www.investindk.com National Experimental Therapy Partnership (NEXT) NEXT is a public-private partnership within clinical research offering a one stop

More information

Genetics and Bioinformatics

Genetics and Bioinformatics Genetics and Bioinformatics Kristel Van Steen, PhD 2 Montefiore Institute - Systems and Modeling GIGA - Bioinformatics ULg kristel.vansteen@ulg.ac.be Lecture 1: Setting the pace 1 Bioinformatics what s

More information

Bridging the Gap Between Basic and Clinical Research. Julio E. Celis Danish Cancer Society

Bridging the Gap Between Basic and Clinical Research. Julio E. Celis Danish Cancer Society Bridging the Gap Between Basic and Clinical Research Julio E. Celis Danish Cancer Society Barriers and Oportunities in Translational Research Promise of the new technologies What is Europe doing? Challenges

More information

Biomedical Informatics in BIG DATA Era

Biomedical Informatics in BIG DATA Era Biomedical Informatics in BIG DATA Era Yang C. Fann, Ph.D. Director, Intramural IT and Bioinformatics Program National Institute of Neurological Disorders and Stroke Disclaimer The opinions or assertions

More information

ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure

ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure Marialuisa Lavitrano Università Milano-Bicocca Coordinatore BBMRI-Italia

More information

Human Microbiome Project: A Community Resource. Lita M. Proctor, Ph.D. Coordinator, Human Microbiome Project NHGRI/NIH

Human Microbiome Project: A Community Resource. Lita M. Proctor, Ph.D. Coordinator, Human Microbiome Project NHGRI/NIH Human Microbiome Project: A Community Resource Lita M. Proctor, Ph.D. Coordinator, Human Microbiome Project NHGRI/NIH 2016 HIV Microbiome Workshop November 17, 2016 1 Human Microbiome Project: 2007 to

More information

Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015

Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015 Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015 Dr. I.J. Nijman Disclosure slide (Potential) conflict of interest None For this meeting relevant

More information

Precision Medicine. Presented by:

Precision Medicine. Presented by: Precision Medicine Presented by: Prepared Brendan FitzGerald For: Enabling better health through information technology. Healthcare Information and Management Systems Society (HIMSS) HIMSS is a global,

More information

Polo Bibliotecario di Scienze, Farmacologia e Scienze Farmaceutiche. Scuola di Dottorato di Ricerca in Scienze Molecolari

Polo Bibliotecario di Scienze, Farmacologia e Scienze Farmaceutiche. Scuola di Dottorato di Ricerca in Scienze Molecolari Polo Bibliotecario di Scienze, Farmacologia e Scienze Farmaceutiche Scuola di Dottorato di Ricerca in Scienze Molecolari Open research data Scuola di Dottorato di Ricerca in Scienze Molecolari Information

More information

MediSapiens Ltd. Because data is not knowledge. 4th of November Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd

MediSapiens Ltd. Because data is not knowledge. 4th of November Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd 4th of November 2014 MediSapiens Ltd Because data is not knowledge Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2014 MediSapiens Ltd. All rights reserved. medisapiens.com MediSapiens Brief

More information

Challenges during the development of ATMPs

Challenges during the development of ATMPs Challenges during the development of ATMPs CAT-DGTI Workshop Dresden 11.9.2014 Paula Salmikangas CAT Chair An agency of the European Union Gene Therapy Medicinal Products Somatic Cell Therapy Medicinal

More information

The International Consortium for Personalised Medicine

The International Consortium for Personalised Medicine The International Consortium for Personalised Medicine Mairead O Driscoll Alliance for Biomedical Research in Europe, 8 November 2017 Personalised Medicine A definition Characterisation of individuals

More information

Linguamatics NLP for Electronic Health Records

Linguamatics NLP for Electronic Health Records 1 Linguamatics 2013 Linguamatics NLP for Electronic Health Records 2 Linguamatics 2013 Click Agenda to to edit edit Master Master title style title style Linguamatics and I2E Overview Customer case studies

More information

Future State Architecture Guide

Future State Architecture Guide Future State Architecture Guide Contents 1 System Architecture... 1 1.1 Modular CRVS Architecture... 1 1.2 Integrated CRVS Architecture... 2 1.3 Interoperable CRVS Architecture... 3 1.4 Strengths and Weaknesses

More information

Supplementary Materials for

Supplementary Materials for www.sciencetranslationalmedicine.org/cgi/content/full/6/242/242cm6/dc1 Supplementary Materials for Sandbox: Building and Sharing Resources This PDF file includes: Mark David Lim E-mail: mlim@fastercures.org

More information

Genetic databases. Anna Sowińska-Seidler, MSc, PhD Department of Medical Genetics

Genetic databases. Anna Sowińska-Seidler, MSc, PhD Department of Medical Genetics Genetic databases Anna Sowińska-Seidler, MSc, PhD seidler@ump.edu.pl Department of Medical Genetics Genetic databases what to start with? www.ncbi.nml.nih.gov NCBI National Center for Biotechnology Information

More information

NIH Institutes and Areas of SBIR Research: (shown in order of FY 2010 Funding amounts)

NIH Institutes and Areas of SBIR Research: (shown in order of FY 2010 Funding amounts) NIH Institutes and Areas of SBIR Research: (shown in order of FY 2010 Funding amounts) 1. NCI (National Cancer Institute) cancer cause, prevention, detection, diagnosis, treatment and control 2. NIAID

More information

BCNet Catalogue Dictionary_v1-1.xlsx 04/12/ :39

BCNet Catalogue Dictionary_v1-1.xlsx 04/12/ :39 The information about Biobank is organized in three different sections: General Information, Services, and Members. Creating a biobank in the system creates its General Information part. General Information

More information

Clinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE

Clinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE Clinical studies BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE www.imbm.sk barboravlk@gmail.com Biomedical research 1. Basic research a. In vitro = cell cultures b. In vivo = experimental animals c.

More information

Lessons learned from Nordic research collaboration The Nordic colon cancer project. Joakim Dillner Director, BBMRI.se (Sweden)

Lessons learned from Nordic research collaboration The Nordic colon cancer project. Joakim Dillner Director, BBMRI.se (Sweden) Lessons learned from Nordic research collaboration The Nordic colon cancer project Joakim Dillner Director, BBMRI.se (Sweden) What is the Nordic advantage, really? -Possibility to link biobanks to nationwide,

More information

Towards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory

Towards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory Towards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory Bull, 2012 Natalia Jiménez Lozano Business Development Manager BULL e-health Consultancy & Business Solutions Tlf: 913939253

More information

Challenges of Personalized Health for Clinical Medicine. Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland

Challenges of Personalized Health for Clinical Medicine. Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland Challenges of Personalized Health for Clinical Medicine Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland Personalisierte Medizin Personalisierte Gesundheit Personalisierte

More information

- OMICS IN PERSONALISED MEDICINE

- OMICS IN PERSONALISED MEDICINE SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary

More information

Amendment of the Work Programme 2017 version 1

Amendment of the Work Programme 2017 version 1 AMENDMENT OF THE CORE WORK PROGRAMME 2017 Version 1.1 Prepared for the consideration of the AoM#9 11 April 2017 1 This document is concerned with amendments to the Core Work Programme 2017. It contains

More information

That ll be the day. From Trends to Scenarios to Strategy Example from health care / Martin Kruse. Agenda

That ll be the day. From Trends to Scenarios to Strategy Example from health care / Martin Kruse. Agenda Copenhagen Institute for Futures Studies International independent non-profit organization with 45 years of experience as strategic advisors Members From Trends to Scenarios to Strategy Example from health

More information

Norwegian experience with meeting public sector requirements

Norwegian experience with meeting public sector requirements Norwegian experience with meeting public sector requirements SEMIC.EU Methodology workshop Brüssels 2 february 2009 Mona Naomi Lintvedt, senior adviser Agency for Public Management and egovernment In Norwegian:

More information

Pharmacogenetics of Drug-Induced Side Effects

Pharmacogenetics of Drug-Induced Side Effects Pharmacogenetics of Drug-Induced Side Effects Hui - Ching Huang Department of Pharmacy, Yuli Hospital DOH Department of Pharmacology, Tzu Chi University April 20, 2013 Brief history of HGP 1953: DNA

More information

Promoting Free Flow of Health Data. Peter Walgemoed, Carelliance

Promoting Free Flow of Health Data. Peter Walgemoed, Carelliance Promoting Free Flow of Health Peter Walgemoed, Carelliance curation with (EU) Citizen design. Paper 2016 2 Health Eco-system stakeholders Health Client Shared Personal Case Decision Making to Improve Quality

More information

TEXT MINING: THE NEXT DATA FRONTIER

TEXT MINING: THE NEXT DATA FRONTIER TEXT MINING: THE NEXT DATA FRONTIER An infrastructural approach for mining scientific content Natalia Manola Athena Research & Innovation Center OpenMinTeD OUTLINE Text mining on scientific content What

More information

How European RIs can boost Open Science & Open Innovation

How European RIs can boost Open Science & Open Innovation How European RIs can boost Open Science & Open Innovation Kurt Zatloukal, Medical University Graz, Austria Corbel Innovation Meeting Brussels, June 20th, 2017 Grant agreement No 654248 Funded by GZ 10.470/0016-II/3/2013

More information